Citius Oncology Inc. (CTOR)
NASDAQ: CTOR
· Real-Time Price · USD
1.70
-0.05 (-2.86%)
At close: Aug 19, 2025, 3:59 PM
1.72
1.47%
Pre-market: Aug 20, 2025, 04:02 AM EDT
Citius Oncology Income Statement
Financials in USD. Fiscal
year is
undefined.
| Fiscal Year | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Apr 30, 2021 |
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -4.94M | -7.47M | -6.39M | -6.67M | -383.96K | -268.43K | -244.14K | -421.45K | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Income | n/a | n/a | n/a | n/a | 636.42K | 758.26K | 1.28M | 579.4K | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -5.11M | -7.47M | -6.39M | -6.67M | 252.46K | 489.83K | -4.58M | 157.94K | n/a | n/a | n/a | n/a | n/a | -9.39K |
Net Income | -5.37M | -7.74M | -6.66M | -6.81M | -4.77M | 489.83K | -4.73M | 157.94K | n/a | n/a | n/a | -8.57K | -2.3K | -9.39K |
Selling & General & Admin | 4.01M | 4.33M | 5.13M | 5.37M | 3.5M | 3.34M | 3.43M | 3.89M | n/a | n/a | n/a | n/a | n/a | n/a |
Research & Development | 938.28K | 3.14M | 1.26M | 1.3M | 1.13M | 1.35M | 1.15M | 1.15M | n/a | n/a | n/a | n/a | n/a | n/a |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -4.62M | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 4.94M | 7.47M | 6.39M | 6.67M | 4.63M | 4.69M | 4.58M | 421.45K | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Expense | 160.75K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 4.94M | 7.47M | 6.39M | 6.67M | 4.63M | 4.69M | 4.58M | 421.45K | n/a | n/a | n/a | n/a | n/a | n/a |
Income Tax Expense | 264.24K | 264.24K | 264.24K | 6.81K | 4.77K | 4.83K | 4.73K | 5.19K | 2.73K | 2.93K | 1.85K | 8.57K | 2.3K | n/a |
Shares Outstanding (Basic) | 71.55M | 71.55M | 71.55M | 71.55M | 66.53M | 66.53M | 89.41M | 89.42M | 90.16M | 90.16M | 90.16M | 90.16M | 81.4M | 66.42M |
Shares Outstanding (Diluted) | 71.55M | 71.55M | 71.55M | 71.55M | 66.53M | 66.53M | 89.41M | 89.42M | 90.16M | 90.16M | 90.16M | 90.16M | 81.4M | 66.42M |
EPS (Basic) | -0.07 | -0.11 | -0.09 | -0.31 | 0.04 | 0.07 | 0.12 | 0.02 | 0.07 | 0.07 | 0.04 | -0.00 | -0.00 | -0.00 |
EPS (Diluted) | -0.07 | -0.11 | -0.09 | -0.31 | 0.04 | 0.07 | 0.12 | 0.02 | 0.07 | 0.07 | 0.04 | -0.00 | -0.00 | -0.00 |
EBITDA | -4.94M | -7.47M | -6.39M | n/a | 252.46K | 489.83K | 1.03M | 157.94K | n/a | n/a | n/a | n/a | n/a | -9.39K |
EBIT | -4.94M | -7.47M | -6.39M | -6.67M | 252.46K | 489.83K | 1.03M | 157.94K | n/a | n/a | n/a | n/a | n/a | -9.39K |
Depreciation & Amortization | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |